Search Browse Earnings

XOMA Royalty Corp — SlamSEC

XOMA Royalty Corp

Nasdaq:XOMANasdaq:XOMAONasdaq:XOMAP

Pharmaceutical Preparations·EMERYVILLE, CA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$2.6M

-36.1% YoY

FY 2024

Adj. EBITDA

-$41.5M

-1567.8% margin

FY 2024

Net Income

-$40.8M

-1540.8% margin

FY 2024

EPS (Diluted)

-$4.04

FY 2024

Stock Price

$26.51

+0.8%

2026-03-09

52W Range

$18.35 – $39.92

P/E Ratio

-6.6x

Market Cap

$328.3M

Cash

$153.3M

FY 2024

Total Debt

$118.5M

FY 2024

Net Cash

$34.8M

FY 2024

Enterprise Value

$293.5M

Debt / EBITDA

0.8x

FY 2024

EV / EBITDA

-7.1x

Employees

—